CYP2B6 p.Pro428Thr
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_000767.5(CYP2B6):c.1282C>A(p.Pro428Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,942 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000767.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000767.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP2B6 | TSL:1 MANE Select | c.1282C>A | p.Pro428Thr | missense | Exon 8 of 9 | ENSP00000324648.2 | P20813-1 | ||
| CYP2B6 | TSL:1 | n.647+318C>A | intron | N/A | |||||
| CYP2B6 | c.937C>A | p.Pro313Thr | missense | Exon 6 of 7 | ENSP00000533417.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152084Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000518 AC: 13AN: 251056 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000230 AC: 35AN: 152084Hom.: 1 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.